Acquired epidermodysplasia verruciformis in setting of tumor necrosis factor-α inhibitor therapy

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)805-807
Number of pages3
JournalJAAD Case Reports
Volume4
Issue number8
DOIs
StatePublished - Sep 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • acquired epidermodysplasia verruciformis
  • human papillomavirus
  • immunosuppression
  • tumor necrosis factor-α inhibitor therapy

Cite this